Medifast Inc. (MED)
NYSE · Miscellaneous Food Preparations & Kindred Products · Manufacturing · CIK 910329 · fiscal year ends in Dec
Closing price $12.24 on 30 Oct 2026; 52-week range $9.45 to $13.15.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $299.6M
- Revenue growth
- -30.3%
- Net income, last twelve months
- -$40.9M
- Earnings per share
- -$3.69
- Gross margin
- 69.2%
- Operating margin
- -11.6%
- Net margin
- -13.6%
- Free cash flow
- -$3.9M
- Return on equity
- -22.7%
- Market value
- $136.9M
- Dividend yield
- 0.0%
- Cash
- $58.4M
- Debt
- $0
- Debt to equity
- 0.00
- Shares outstanding
- 11.2M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $385.8M | -$14.2M | -$18.7M | -$1.70 | $1.2M | 10-K filed 17 Feb 2026 |
| FY2024 | 31 Dec 2024 | $602.5M | $2.9M | $2.1M | $0.19 | $17.0M | 10-K filed 18 Feb 2025 |
| FY2023 | 31 Dec 2023 | $1.1B | $126.4M | $99.4M | $9.10 | $141.2M | 10-K filed 20 Feb 2024 |
| FY2022 | 31 Dec 2022 | $1.6B | $184.8M | $143.6M | $12.73 | $177.9M | 10-K filed 20 Feb 2024 |
| FY2021 | 31 Dec 2021 | $1.5B | $216.2M | $164.0M | $13.89 | $60.3M | 10-K filed 20 Feb 2024 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $72.0M | -$17.5M | -$1.57 |
| Q2 FY2026 | 30 Jun 2026 | $76.4M | -$3.1M | -$0.28 |
| Q1 FY2026 | 31 Mar 2026 | $76.0M | -$2.1M | -$0.19 |
| Q4 FY2025 | 31 Dec 2025 | $75.1M | -$18.1M | -$1.65 |
| Q3 FY2025 | 30 Sep 2025 | $89.4M | -$2.3M | -$0.21 |
| Q2 FY2025 | 30 Jun 2025 | $105.6M | $2.5M | $0.22 |
| Q1 FY2025 | 31 Mar 2025 | $115.7M | -$772.0K | -$0.07 |
| Q4 FY2024 | 31 Dec 2024 | $119.0M | $800.0K | $0.07 |
Company events
The newest 8-K filings of 232 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 26 Oct 2026 | 8-K | Results | 2.02, 9.01 |
| 3 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 17 Jul 2026 | 8-K | Investor update | 7.01, 9.01 |
| 1 Jun 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 26 May 2026 | 8-K | Leadership change, Shareholder vote, Investor update | 5.02, 5.07, 7.01, 9.01 |
| 4 May 2026 | 8-K | Results | 2.02, 9.01 |
| 20 Mar 2026 | 8-K | Leadership change, Material agreement, Investor update | 1.01, 5.02, 7.01, 9.01 |
| 17 Feb 2026 | 8-K | Results | 2.02, 9.01 |
| 5 Jan 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 3 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 4 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 20 Jun 2025 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
Every filing
The newest filings with the SEC of 520 held.
| Filed | Form | Period |
|---|---|---|
| 26 Oct 2026 | 10-Q | 30 Sep 2026 |
| 26 Oct 2026 | 8-K | 26 Oct 2026 |
| 3 Aug 2026 | S-8 | – |
| 3 Aug 2026 | 10-Q | 30 Jun 2026 |
| 3 Aug 2026 | 8-K | 3 Aug 2026 |
| 17 Jul 2026 | 8-K | 17 Jul 2026 |
| 1 Jun 2026 | 8-K | 29 May 2026 |
| 26 May 2026 | 8-K | 19 May 2026 |
| 4 May 2026 | 10-Q | 31 Mar 2026 |
| 4 May 2026 | 8-K | 4 May 2026 |
| 30 Apr 2026 | DEFA14A | – |
| 6 Apr 2026 | ARS | 31 Dec 2025 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | Kiai Parsa, Director | Purchase | 5,399 | $12.24 | $66.1K | 712,891 | 30 Oct 2026 |
| 28 Oct 2026 | Kiai Parsa, Director | Purchase | 158 | $12.24 | $1.9K | 20,428 | 30 Oct 2026 |
| 29 Sep 2026 | Chard Daniel R, Director | Sale under a trading plan | 9,544 | $11.73 | $112.0K | 130,609 | 30 Sep 2026 |
| 28 Sep 2026 | Chard Daniel R, Director | Sale under a trading plan | 9,545 | $11.98 | $114.3K | 140,153 | 30 Sep 2026 |
| 26 Aug 2026 | Kiai Parsa, Director | Purchase | 41,975 | $12.26 | $514.7K | 707,492 | 28 Aug 2026 |
| 26 Aug 2026 | Kiai Parsa, Director | Purchase | 1,175 | $12.26 | $14.4K | 20,270 | 28 Aug 2026 |
| 24 Aug 2026 | Kiai Parsa, Director | Purchase | 4,211 | $12.00 | $50.5K | 665,517 | 26 Aug 2026 |
| 24 Aug 2026 | Kiai Parsa, Director | Purchase | 118 | $12.00 | $1.4K | 19,095 | 26 Aug 2026 |
| 20 Aug 2026 | Kiai Parsa, Director | Purchase | 41,975 | $11.60 | $487.1K | 661,306 | 21 Aug 2026 |
| 20 Aug 2026 | Kiai Parsa, Director | Purchase | 1,175 | $11.60 | $13.6K | 18,977 | 21 Aug 2026 |
| 19 Aug 2026 | Kiai Parsa, Director | Purchase | 28,538 | $11.66 | $332.7K | 619,331 | 21 Aug 2026 |
| 19 Aug 2026 | Kiai Parsa, Director | Purchase | 799 | $11.66 | $9.3K | 17,802 | 21 Aug 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 29 Sep 2026 | Chard Daniel R, Officer | 9,544 | $112.0K | 29 Sep 2026 |
| 28 Sep 2026 | Chard Daniel R, Officer | 9,545 | $114.3K | 28 Sep 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 21 Aug 2026 | Steamboat Capital Partners, LLC | 13D amended | 7.1% | 790.7K |
| 14 Aug 2026 | Susquehanna Portfolio Strategies, LLC | 13G | 5.3% | 587.2K |
| 14 Aug 2026 | Citadel Securities GP LLC | 13G amended | 2.6% | 289.8K |
| 12 Aug 2026 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13G amended | 3.6% | 397.0K |
| 29 Jul 2026 | BlackRock, Inc. | 13G amended | 2.9% | 327.4K |
| 15 May 2026 | Citadel Securities GP LLC | 13G | 6.5% | 715.9K |
| 14 May 2026 | Renaissance Technologies LLC | 13G amended | 6.96% | 773.7K |
| 14 May 2026 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13G amended | 5.74% | 0 |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 20 Mar 2026 | Steamboat Capital Partners, LLC | 13D | 6% | 657.6K |
Trades by members of the House
From each member's periodic transaction report.
| Traded | Member | Type | Amount | Disclosed |
|---|---|---|---|---|
| 24 Jun 2019 | Donna Shalala (FL27) | Sale | $1,001 - $15,000 | 27 Apr 2020 |
| 30 Apr 2019 | Donna Shalala (FL27) | Purchase | $1,001 - $15,000 | 27 Apr 2020 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 1.2M | +9.91% | 11.36 |
| 30 Sep 2026 | 1.1M | -43.44% | 7.3 |
| 15 Sep 2026 | 1.9M | -1.11% | 20.02 |
| 31 Aug 2026 | 1.9M | +3.22% | 15.11 |
| 14 Aug 2026 | 1.8M | +22.89% | 7.42 |
| 31 Jul 2026 | 1.5M | -9.46% | 9.16 |
| 15 Jul 2026 | 1.6M | +4.99% | 9.41 |
| 30 Jun 2026 | 1.6M | -27.56% | 3.69 |
Funds that hold it
From each fund's latest Form 13F.
137 funds held it at 30 Jun 2026: 65 added and 28 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| Renaissance Technologies LLC | 778,610 | $8.3M | +4,900 |
| Steamboat Capital Partners, LLC | 706,699 | $7.5M | -891 |
| Two Sigma Investments, LP | 481,381 | $5.1M | +143,223 |
| Vanguard Capital Management LLC | 446,614 | $4.7M | +2,147 |
| Charles Schwab Investment Management Inc. | 396,996 | $4.2M | -234,543 |
| BlackRock, Inc. | 369,503 | $3.9M | -574,950 |
| Dimensional Fund Advisors LP | 363,394 | $3.9M | +1,632 |
| American Century Companies Inc. | 318,911 | $3.4M | +94,631 |
| Morgan Stanley | 292,508 | $3.1M | -32,804 |
| Goldman Sachs Group Inc. | 243,085 | $2.6M | +89,914 |
Peers
Companies in the same industry.
- McCormick & Co. Inc. (MKC): revenue $7.7B, market value $12.7B
- Utz Brands, Inc. (UTZ): revenue $1.5B, market value $2.1B